----

----

----

|  Florida                                                                       |   |  65-0736042                                    |
|-------------------------------------------------------------------------------------|--------|-----------------------------------------------------|
|  (State      or Other Jurisdiction ofIncorporation      or Organization)  |   |  (I.R.S.      EmployerIdentification      No.) |

| c/o      Olshan Grundman Frome et al.65 East      55th Street, New York, New York |   |  10022           |
|----------------------------------------------------------------------------------------|--------|-----------------------|
|  (Address      of Principal Executive Offices)                                    |   |  (Zip      Code) |

|  Issuer’s      telephone number, including area code:  |   |   (212)      451-2254 |
|------------------------------------------------------------------------|--------|---------------------------------|

----

TABLE OF CONTENTS

|         | PART      I                                                          | Page    |
|--------------|----------------------------------------------------------------------|---------|
|         |                                                                 |    |
| Item      1. | FINANCIAL      STATEMENTS                                            | 1       |
| Item      2. | MANAGEMENT’S      DISCUSSION AND ANALYSIS OR PLAN OF OPERATION | 7       |
| Item      3. | QUANTITATIVE      AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.     | 8       |
| Item      4. | CONTROLS      AND PROCEDURES                                         | 8       |
|         |                                                                 |    |
|         | PART      II                                                         |    |
|         |                                                                 |    |
| Item      1. | LEGAL      PROCEEDINGS                                               | 9       |
| Item      2. | UNREGISTERED      SALES OF EQUITY SECURITIES AND USE OF PROCEEDS     | 9       |
| Item      3. | DEFAULTS      UPON SENIOR SECURITIES                                 | 9       |
| Item      4. | SUBMISSION      OF MATTERS TO A VOTE OF SECURITIY HOLDERS            | 9       |
| Item      5. | OTHER      INFORMATION                                               | 9  |
| Item      6. | EXHIBITS                                                             | 9       |
| SIGNATURES   |                                                                 | 10      |
| EXHIBITS     |                                                                 |    |

----

----

----

|  Balance      sheets             |  1   |
|-------------------------------------------------|-----------|
|                                            |      |
|  Statements of      operations   |  2   |
|                                            |      |
|  Statements of      cash flows             |  3-4 |
|                                            |      |
|  Notes to      financial statements   |  5-6 |
|                                            |      |

----

|                                                                       |   | (unaudited) |          |   |     |   |
|----------------------------------------------------------------------------|--------|-------------|---------------|--------|----------|--------|
| ASSETS                                                                     |   | SEPTEMBER   |          |   | DECEMBER |   |
|                                                                       |   |        | 30,      2008 |   |     |   | 31,      2007 |   |
|                                                                       |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
| CURRENT      ASSETS:                                                       |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
| Cash                                                                       |   | $           | -             |   |     | $      | 84 |   |
|                                                                       |   |        |          |   |     |   |   |   |
| Total      current assets                                                  |   |        | -             |   |     |   | 84 |   |
|                                                                       |   |        |          |   |     |   |   |   |
| TOTAL      ASSETS                                                          |   | $           | 0             |   |     | $      | 84 |   |
|                                                                       |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
| LIABILITIES      AND STOCKHOLDERS’ DEFICIENCY                        |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
| CURRENT      LIABILITIES:                                                  |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
| Accounts      payable and accrued expenses                                 |   | $           | 98,549        |   |     | $      | 99,278 |   |
| Accounts      payable - related party                                      |   |        | 21,823        |   |     |   | 6,030 |   |
| Notes      payable - related party                                         |   |        | 69,859        |   |     |   | 61,009 |   |
|                                                                       |   |        |          |   |     |   |   |   |
| Total      current liabilities                                             |   |        | 190,231       |   |     |   | 166,317 |   |
|                                                                       |   |        |          |   |     |   |   |   |
| STOCKHOLDERS’      DEFICIENCY:                                       |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
| Preferred      stock, par value $.0001 per share; 10,000,000 shares        |   |        |          |   |     |   |   |   |
|   authorized;      none issued and outstanding                   |   |        |          |   |     |   |   |   |
|   at      September 30, 2007 and December 31, 2006, respectively |   |        | --            |   |     |   | -- |   |
| Common      stock, par value $.0001 per share; 50,000,000 shares           |   |        |          |   |     |   |   |   |
|   authorized;      392,457 shares issued and outstanding         |   |        |          |   |     |   |   |   |
|   at      September 30, 2007 and December 31, 2006, respectively |   |        | 40            |   |     |   | 40 |   |
| Additional      paid-in capital                                            |   |        | 137,008       |   |     |   | 137,008 |   |
| Deficit      accumulated during the development stage                      |   |        | (327,279      | )      |     |   | (303,281 | ) |
|                                                                       |   |        |          |   |     |   |   |   |
|   Total      stockholders’ deficiency                      |   |        | (190,231      | )      |     |   | (166,233 | ) |
|                                                                       |   |        |          |   |     |   |   |   |
|   TOTAL      LIABILITIES AND STOCKHOLDERS’ DEFICIENCY      |   | $           | 0             |   |     | $      | 84 |   |
|                                                                       |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |
|                                                                       |   |        |          |   |     |   |   |   |

----

|                                   |   |  (UNAUDITED)                  |    |   |  (UNAUDITED)             |   |    | (UNAUDITED)FOR      THE PERIODMARCH      21, 1997(DATE      OF |   |
|----------------------------------------|--------|------------------------------------|---------|--------|-------------------------------|--------|---------|----------------------------------------------------------------|--------|
|                                   |   | NINE      MONTHS ENDEDS      ENDED |    |   |  THREE      MONTHS ENDED |   |    |  INCEPTION)                                               |   |
|                                   |   | SEPTEMBER 30,                 |    |   |  SEPTEMBER 30,           |   |    | TO                                                             |   |
|                                   |   | 2008                               |    |   | 2007                          |   |    | 2008                                                           |   |   | 2007 |   |   | SEPTEMBER      30, 2008 |   |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |
| DEVELOPMENT      STAGE REVENUES        |   | $                                  | 0       |   |                          | $      | 0       |                                                           |   | $ | 0 |   |   | $ | 0 |   |   | $ | 24,728 |   |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| DEVELOPMENT      STAGE EXPENSES:       |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| Accounting      and Auditing           |   |                               | 10,000  |   |                          |   | 19,800  |                                                           |   |   | 3,500 |   |   |   | 6,600 |   |   |   | 130,871 |   |
| Advertising                            |   |                               | 0       |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 30,560 |   |
| Bank      charges                      |   |                               | 260     |   |                          |   | 125     |                                                           |   |   | 75 |   |   |   | 75 |   |   |   | 1,190 |   |
| Consulting      fees                   |   |                               | 0       |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 5,082 |   |
| Legal      fees                        |   |                               | 5,000   |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 53,947 |   |
| Licenses      and taxes                |   |                               | 200     |   |                          |   | 200     |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 2,782 |   |
| Meals      and entertainment           |   |                               | 0       |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 5,248 |   |
| Miscellanous      expenses             |   |                               | 0       |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 1,828 |   |
| Office      general (incl. printing)   |   |                               | 1,124   |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 10,053 |   |
| Payroll      and commissions           |   |                               | 0       |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 14,430 |   |
| Shareholder      related services      |   |                               | 0       |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 2,835 |   |
| Transfer      agent fees               |   |                               | 2,388   |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | 21,395 |   |
| TOTAL      DEVELOPMENT STAGE EXPENSES  |   |                               | 18,972  |   |                          |   | 20,125  |                                                           |   |   | 3,575 |   |   |   | 6,675 |   |   |   | 280,221 |   |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| LOSS      FROM OPERATIONS              |   |                               | (18,972 | )      |                          |   | (20,125 | )                                                              |   |   | (3,575 | ) |   |   | (6,675 | ) |   |   | (255,493 | ) |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| LOSS      ON INVESTMENT - HEALTHCARE   |   |                               | 0       |   |                          |   | 0       |                                                           |   |   | 0 |   |   |   | 0 |   |   |   | (50,016 | ) |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| INTEREST      EXPENSE                  |   |                               | (5,025  | )      |                          |   | (3,980  | )                                                              |   |   | (1,836 | ) |   |   | (1,553 | ) |   |   | (21,770 | ) |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| NET      LOSS                          |   | $                                  | (23,997 | )      |                          | $      | (24,105 | )                                                              |   | $ | (5,411 | ) |   | $ | (8,228 | ) |   | $ | (327,279 | ) |
|                                   |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| LOSS      PER COMMON SHARE             |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic      & diluted               |   | $                                  | (0.06   | )      |                          | $      | (0.06   | )                                                              |   | $ | (0.01 | ) |   | $ | (0.02 | ) |   |   |   |   |
| Weighted-average      number of common |   |                               |    |   |                          |   |    |                                                           |   |   |   |   |   |   |   |   |   |   |   |   |
|  shares      outstanding          |   |                               | 392,457 |   |                          |   | 392,457 |                                                           |   |   | 392,457 |   |   |   | 392,457 |   |   |   |   |   |

----

|                                                   |   |  (unaudited)        |    |   | (unaudited)FOR      THEPERIOD      MARCH      21,1997(DATE      OF |   |
|--------------------------------------------------------|--------|--------------------------|---------|--------|--------------------------------------------------------------------|--------|
|                                                   |   | NINE      MONTHS ENDED   |    |   |  INCEPTION)                                                   |   |
|                                                   |   |  SEPTEMBER      30, |    |   | TO                                                                 |   |
|                                                   |   |                     |    |   |                                                               |   |   | SEPTEMBER |   |
| OPERATING      ACTIVITIES                              |   | 2008                     |    |   | 2007                                                               |   |   |  30,      2008 |   |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |
| Net      loss                                          |   | $                        | (23,997 | )      |                                                               | $      | (24,105 | ) |   | $ | (327,279 | ) |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| Adjustment      to reconcile net loss to net cash      |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| used      by operations                                |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| Shares      issued for consulting services             |   |                     | 0       |   |                                                               |   | 0 |   |   |   | 36,148 |   |
| Shares      issued for termination of HMC              |   |                     | 0       |   |                                                               |   | 0 |   |   |   | 50,000 |   |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| Changes      in assets and liabilities                 |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| Increase      in accounts payable and accrued expenses |   |                     | (730    | )      |                                                               |   | 4,780 |   |   |   | 98,550 |   |
| Increase      in accounts payable and accrued expenses |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| related      party                                     |   |                     | 15,793  |   |                                                               |   | 0 |   |   |   | 21,822 |   |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| Net      cash used by operating activities             |   |                     | (8,934  | )      |                                                               |   | (19,325 | ) |   |   | (120,759 | ) |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| FINANCING      ACTIVITES                               |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| Proceeds      from promissory notes                    |   |                     | 8,850   |   |                                                               |   | 17,000 |   |   |   | 69,859 |   |
| Proceeds      from issuance of common stock            |   |                     | 0       |   |                                                               |   | 0 |   |   |   | 50,900 |   |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| Net      cash provided by financing activites          |   |                     | 8,850   |   |                                                               |   | 17,000 |   |   |   | 120,759 |   |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| CHANGE  IN      CASH                         |   |                     | (84     | )      |                                                               |   | (2,325 | ) |   |   | 0 |   |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| CASH,      BEGINNING OF PERIOD                         |   |                     | 84      |   |                                                               |   | 2,484 |   |   |   | 0 |   |
|                                                   |   |                     |    |   |                                                               |   |   |   |   |   |   |   |
| CASH,      END OF PERIOD                               |   | $                        | (0      | )      |                                                               | $      | 159 |   |   | $ | 0 |   |

----

|                                                  |   |                         |   |   |                                        |   |   | (unaudited)         |   |
|-------------------------------------------------------|--------|------------------------------|--------|--------|---------------------------------------------|--------|--------|---------------------|--------|
|                                                  |   |                         |   |   |                                        |   |   | FOR      THE PERIOD |   |
|                                                  |   |  (unaudited)            |   |   | MARCH      21, 1997(DATE      OF INCEPTION) |   |
|                                                  |   |  NINE      MONTHS ENDED |   |   | TO                                          |   |
|                                                  |   |  SEPTEMBER      30,     |   |   | SEPTEMBER                                   |   |
|                                                  |   | 2008                         |   |   | 2007                                        |   |   | 30, 2008            |   |
|                                                  |   |                         |   |   |                                        |   |   |                |   |
| Supplemental      cash flow information:              |   |                         |   |   |                                        |   |   |                |   |
| Interest      paid                                    |   | $                            | 0      |   |                                        | $      | 0      |                |   | $ | 0 |   |
| Income      taxes paid                                |   | $                            | 0      |   |                                        | $      | 0      |                |   | $ | 0 |   |
|                                                  |   |                         |   |   |                                        |   |   |                |   |   |   |   |
| Noncash      investing and financing activities:      |   |                         |   |   |                                        |   |   |                |   |   |   |   |
| Shares      issued to founder for consulting services |   | $                            | 0      |   |                                        | $      | 0      |                |   | $ | 81 |   |
| Shares      issued for legal services rendered        |   | $                            | 0      |   |                                        | $      | 0      |                |   | $ | 500 |   |

----

----

----

----

----

----

----

----

|                               | CENTRACAN      INCORPORATED |                               |
|------------------------------------|-----------------------------|------------------------------------|
|                               |                        |                               |   |
| Date:      November 13, 2008  | By:                         | /s/ Jerome      Goubeaux,     |   |
|                               |                        | Jerome      Goubeaux,              |   |
|                               |                        | Chief      Executive Officer  |   |
|                               |                        |                               |   |